New CEO in Navamedic ASA
"The Board of Directors is indeed very pleased that Olof Milveden has chosen to accept the position as the new CEO of Navamedic. We are very comfortable that Olof, with his long and varied experience from the industry can develop the company further and continue to build a strong and attractive specialty pharma company", says Johan Reinsli, Chairman of the Board of Navamedic ASA.
Olof Milveden has during his career worked in many different fields within the health care sector such as Pharmaceuticals, Generics, Devices, Diagnostics, and Medical Equipment and has an extensive experience from living and working in different markets under different and difficult market conditions.
"I am very grateful to have been chosen to lead Navamedic and I find it a great personal challenge to develop the company further. I believe that Navamedic has a good foundation to build upon and I see further potential in the existing product range. I am convinced that Navamedic can be an attractive partner in product areas not yet covered by the company today and believe that my international back ground and 27 years of experience from different fields in the pharma / health care sector will facilitate this. In today's mega merger-mania there is always room for a smaller, quicker and leaner company like Navamedic to fill the gaps that are left open when big pharma gets bigger, " says Olof Milveden.
Olof Milveden is 56 years and from Sweden. He will have his office in Gothenburg and starts in the position as CEO today, 4 May.
For further information, please contact:
Johan Reinsli, Chairman of the Board, Navamedic ASA
Mobile: +47 916 04 145
Bernt-Olav Røttingsnes, CFO/IRO Navamedic ASA
E-mail: bor@navamedic.com
Office: +47 67 11 25 44
Mobile: +47 91 34 70 21